Notably, CC1-NPGY no longer exerted inhibitory effect on tumor growth (Figs 6N, 6O, S6N), indicating that the in vivo anti-tumor activity of CC1-NPGY depends on PD-L1. This evidence concerns the gene CD274 and neoplasm.